136 related articles for article (PubMed ID: 35152248)
1. BACILLARY LAYER DETACHMENT IN A KOREAN COHORT WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kim JH; Kim JW; Kim CG
Retina; 2022 Jun; 42(6):1028-1037. PubMed ID: 35152248
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration.
Ramtohul P; Malclès A; Gigon E; Freund KB; Introini U; Bandello F; Cicinelli MV
Ophthalmol Retina; 2022 Mar; 6(3):185-195. PubMed ID: 34587559
[TBL] [Abstract][Full Text] [Related]
3. Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population.
Kim JH; Kim JW; Kim CG
J Ocul Pharmacol Ther; 2022 Apr; 38(3):261-268. PubMed ID: 35119292
[No Abstract] [Full Text] [Related]
4. [Prognosis criteria of optical coherence tomography angiography for the long-term efficacy of anti-VEGF therapy of neovascular age-related macular degeneration].
Fursova AZ; Nikulich IF; Dmitrieva EI; Gusarevich OG; Derbeneva AS; Vasilyeva MA; Kozhevnikova OS; Kolosova NG; Rabota FK
Vestn Oftalmol; 2023; 139(6):50-58. PubMed ID: 38235630
[TBL] [Abstract][Full Text] [Related]
5. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
Shen YS; Cheng CK
Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
[TBL] [Abstract][Full Text] [Related]
6. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE
Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560
[TBL] [Abstract][Full Text] [Related]
7. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
8. Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration.
Cozzi M; Monteduro D; Parrulli S; Ristoldo F; Corvi F; Zicarelli F; Staurenghi G; Invernizzi A
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):781-789. PubMed ID: 34491426
[TBL] [Abstract][Full Text] [Related]
9. EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
Retina; 2019 Oct; 39(10):1953-1958. PubMed ID: 30161096
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
Monés J; Biarnés M;
Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111
[TBL] [Abstract][Full Text] [Related]
11. Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.
Kim KT; Chae JB; Lee S; Seo EJ; Kim DY
BMC Ophthalmol; 2021 Aug; 21(1):294. PubMed ID: 34376158
[TBL] [Abstract][Full Text] [Related]
12. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
[TBL] [Abstract][Full Text] [Related]
13. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
14. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Boiko EV; Maltsev DS
Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
[TBL] [Abstract][Full Text] [Related]
15. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
16. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
17. QUANTIFIED ANASTOMOTIC AREAS OF NEOVASCULARIZATION AS FACTORS ASSOCIATED WITH FREQUENT RECURRENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Lee H; Kim S; Kim MA; Chung H; Kim HC
Retina; 2023 May; 43(5):747-754. PubMed ID: 36729565
[TBL] [Abstract][Full Text] [Related]
18. Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degeneration.
Faatz H; Rothaus K; Ziegler M; Book M; Spital G; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
Int Ophthalmol; 2022 May; 42(5):1553-1562. PubMed ID: 35028773
[TBL] [Abstract][Full Text] [Related]
19. [Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration].
Budzinskaya MV; Shelankova AV; Andreeva AA; Plyukhova AA; Afanasyeva MA
Vestn Oftalmol; 2021; 137(5):7-13. PubMed ID: 34726852
[TBL] [Abstract][Full Text] [Related]
20. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]